Genetic Technologies Limited (ASX:GTG)
Australia · Delayed Price · Currency is AUD 0.0390
0.00 (0.00%)
Oct 16, 2024, 1:07 PM AEST
Genetic Technologies Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Revenue | - | - | - | 8.69 | 6.79 |
Other Revenue | 0 | 0.99 | 1.85 | 1.66 | 2.42 |
| 0 | 0.99 | 1.85 | 10.35 | 9.22 | |
Revenue Growth | -99.97% | -46.41% | -82.13% | 12.25% | 590.65% |
Cost of Revenue | - | 0.2 | - | 4.34 | 3.01 |
Gross Profit | 0 | 0.79 | 1.85 | 6.01 | 6.2 |
Selling, General & Admin | 0.39 | 2.5 | 5.12 | 10.52 | 9.75 |
Research & Development | - | 0 | - | 1.28 | 0.71 |
Other Operating Expenses | 0.04 | 0.63 | 2.51 | 3.67 | 2.15 |
Operating Expenses | 0.43 | 3.21 | 8.11 | 16.43 | 13.75 |
Operating Income | -0.43 | -2.43 | -6.26 | -10.42 | -7.54 |
Interest Expense | - | -0.04 | -0.05 | -0.03 | -0.02 |
Interest & Investment Income | - | 0.02 | 0.12 | 0.22 | 0.04 |
Currency Exchange Gain (Loss) | - | - | - | 0.16 | 0.36 |
Other Non Operating Income (Expenses) | - | 0 | - | - | - |
EBT Excluding Unusual Items | -0.43 | -2.44 | -6.19 | -10.06 | -7.16 |
Impairment of Goodwill | - | - | - | -1.85 | - |
Asset Writedown | - | -1.63 | - | - | - |
Other Unusual Items | - | 3.65 | - | - | - |
Pretax Income | -0.43 | -0.43 | -6.19 | -11.91 | -7.16 |
Income Tax Expense | - | - | - | -0.16 | -0.03 |
Earnings From Continuing Operations | -0.43 | -0.43 | -6.19 | -11.75 | -7.13 |
Earnings From Discontinued Operations | - | -1.03 | -5.83 | - | - |
Net Income | -0.43 | -1.46 | -12.02 | -11.75 | -7.13 |
Net Income to Common | -0.43 | -1.46 | -12.02 | -11.75 | -7.13 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 1,429 | 1,335 | 132 | 101 | 92 |
Shares Outstanding (Diluted) | 1,429 | 1,335 | 132 | 101 | 92 |
Shares Change | 6.98% | 910.02% | 30.42% | 9.95% | 7.91% |
EPS (Basic) | -0.00 | -0.00 | -0.09 | -0.12 | -0.08 |
EPS (Diluted) | -0.00 | -0.00 | -0.09 | -0.12 | -0.08 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -0.11 | -1.36 | -9.71 | -9.74 | -5.72 |
Free Cash Flow Per Share | - | -0.00 | -0.07 | -0.10 | -0.06 |
Gross Margin | 100.00% | 79.44% | 100.00% | 58.10% | 67.31% |
Operating Margin | -166771.60% | -244.87% | -338.61% | -100.66% | -81.84% |
Profit Margin | -166771.60% | -147.70% | -650.02% | -113.56% | -77.36% |
Free Cash Flow Margin | -43594.16% | -137.09% | -525.33% | -94.13% | -62.09% |
EBITDA | -0.35 | -2.35 | -6.02 | -10.04 | -7.2 |
EBITDA Margin | - | -237.00% | - | -96.99% | -78.11% |
D&A For EBITDA | 0.08 | 0.08 | 0.24 | 0.38 | 0.34 |
EBIT | -0.43 | -2.43 | -6.26 | -10.42 | -7.54 |
EBIT Margin | - | -244.87% | - | -100.66% | -81.84% |
Revenue as Reported | 0 | 4.9 | 1.97 | - | - |
Advertising Expenses | - | 0.05 | - | 2.71 | 1.89 |